AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications

The abnormal BCR-ABL oncoprotein is a constitutively active tyrosine kinase driving aberrant proliferation of transformed hematopoietic cells. BCR-ABL regulates activation of many mitogenic and pro-survival pathways, including the PI 3'K/AKT/mTOR pathway that controls various effectors and regu...

Descripción completa

Detalles Bibliográficos
Autores principales: Vakana, Eliza, Platanias, Leonidas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2011
Materias:
Research Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282089/
https://www.ncbi.nlm.nih.gov/pubmed/22249159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282089/
https://www.ncbi.nlm.nih.gov/pubmed/22249159

Ejemplares similares